This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
But despite the supportive landscape for rare disease therapies, pharmacompanies still struggle to launch on time, if at all. But despite the supportive landscape for rare disease therapies, pharmacompanies still struggle to launch on time, if at all.
Streamlining Compliance: Outsourcing combined services and technology in pharmacovigilance and regulatory affairs Biotech and pharmacompanies are already tapping into the benefits of outsourcing. Download now to learn more. Download now to learn more. Download now to learn more.
Gain timely, up-to-the-minute insights on: CMS’ Proposed Rule 340B Program State Price Transparency Value-Based Contracts Dispute Resolution Bona Fide Service Fees Class of Trade FSS Contracts State Invoicing Policy Initiatives Election Implications And many other critical topics.
Data from the survey has produced enlightening insights about the priorities of both large and small/mid-size pharmacompanies that can be used to guide business decisions. DOWNLOAD OUR REPORT The post Survey Sheds Light on Current Trends & Opportunities in Site and Patient Recruitment appeared first on PPD Inc.
Pharma leaders fear extreme vulnerability in end-to-end supply chain as pandemic continues, according to global survey. Explore how pharmacompanies and industry leaders can reset for growth in the lab beyond coronavirus in Pharma IQ ’s fourth annual edition of Smart Lab Digital. Download a copy of the report here.
Just choose your preferred event and prepare to walk away inspired and armed with the knowledge necessary to drive patient access forward. Which event is for you?
In an effort to slow the spread of the disease and prevent a second wave, pharmacompanies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. Source link.
SeaCube Containers , a pharmaceutical cargo trade company, has acquired 200 storage containers developed by Carrier and Sensitech to help address the anticipated increase in demand for refrigerated storage capacity and cargo visibility in support of Covid-19 vaccine distribution.
As pharmacompanies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. Download Medidata’s white paper to learn how to virtualize clinical trials and bring new therapies closer to patients. Source link.
For larger queries, users should look at OTG’s data download options. Although pharmacompanies can be competitive, this kind of tool will not generate any IP, and it saved us so much work that we knew it could be of real benefit to the community. What are the limits of this application?
For more information on how to build effective and compliant engagement plans, download our white paper: How AI Can Save Medical Affairs from Drowning in Data. It is a vital component in building trust and maintaining ethical standards in the healthcare industry.
For more information on key components of a fit-for-purpose, phase-by-phase QMS guidance download Advarra’s whitepaper Steps to Implementing a Quality Management System. The sponsor-initiated IND is conducted by a pharmacompany seeking commercial approval. Q: What must be done to prove oversight?
Phages that can be essentially downloaded and synthesized by anyone, in any location, would solve those problems, he says. This process would begin by taking a sample of bacteria from the patient and sequencing its DNA.
The demand for an effective drug for nail fungus is high and MOB-015 can achieve a unique market position through its high antifungal effect,” says Anna Ljung, CEO of Moberg Pharma. The following files are available for download: View original content: [link]. SOURCE Moberg Pharma.
CET on November 6, 2020.
Techbio companies have initiated this approach. Now even non-AI native big pharmacompanies take a similar view on using clinical genomics with integrated multimodality. The synergy between regulatory, technological and methodological changes has had a positive impact on the entire drug development cycle.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content